SZShangchao Zhang
Shangchao Zhang
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shangchao Zhang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Guang Yang
School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
1 shared publication - Huiping Zhang
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; VA Medical Center, VA Connecticut Healthcare System, West Haven, CT, USA
1 shared publication - Jieping Shi
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China
1 shared publication - Na Zhou
State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wailong, Taipa, Macau, People’s Republic of China
1 shared publication - Qiong Yu
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, 130021, China
1 shared publication - Rui Liu
NHC Key Laboratory of Radiobiology (Jilin University)
1 shared publication
Latest Publications
- Open Access
- 1 January 2017
- Published by Wiley in Disease Markers
- Vol. 2017, 1-5
A Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia
Our previous studies using the mass spectrum analysis provided evidence that fibrinopeptide A (FPA) could be a potential biomarker for schizophrenia diagnosis. We sought further to demonstrate that variants in the fibrinogen alpha chain gene (FGA) coded FPA might confer vulnerability to schizophrenia. 1,145 patients with schizophrenia and 1,016 healthy volunteers from the Han population in Northeast China were recruited. The association of three tag single nucleotide polymorphisms (SNPs) (rs2070011 in the UTR, rs2070016 in intron 4, and rs2070022 in the UTR) in FGA and schizophrenia was examined using a case-control study design. Genotypic distributions of these three SNPs were not found to be significantly different between cases and controls (rs2070011: , ; rs2070016: , ; rs2070022: , ). There were also no significant differences in SNP allelic frequencies between cases and controls (all ). Additionally, the frequency of haplotypes consisting of alleles of these three SNPs was not significantly different between cases and healthy control subjects (global , ). Our study did not show a significant association of FGA SNPs with schizophrenia. Future studies may need to test more FGA SNPs in a larger sample to identify those SNPs with a minor or moderate effect on schizophrenia.- 1 January 2017
- Published by Wiley in Disease Markers
- Vol. 2017, 1-5
Open AccessA Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia
Our previous studies using the mass spectrum analysis provided evidence that fibrinopeptide A (FPA) could be a potential biomarker for schizophrenia diagnosis. We sought further to demonstrate that variants in the fibrinogen alpha chain gene (FGA) coded FPA might confer vulnerability to schizophrenia. 1,145 patients with schizophrenia and 1,016 healthy volunteers from the Han population in Northeast China were recruited. The association of three tag single nucleotide polymorphisms (SNPs) (rs2070011 in the UTR, rs2070016 in intron 4, and rs2070022 in the UTR) in FGA and schizophrenia was examined using a case-control study design. Genotypic distributions of these three SNPs were not found to be significantly different between cases and controls (rs2070011: , ; rs2070016: , ; rs2070022: , ). There were also no significant differences in SNP allelic frequencies between cases and controls (all ). Additionally, the frequency of haplotypes consisting of alleles of these three SNPs was not significantly different between cases and healthy control subjects (global , ). Our study did not show a significant association of FGA SNPs with schizophrenia. Future studies may need to test more FGA SNPs in a larger sample to identify those SNPs with a minor or moderate effect on schizophrenia.